Lumida
/OVID
⌘K
Ovid Therapeutics Inc

Ovid Therapeutics Inc

OVID
$2.69USD+2.28%+0.06 today

MARKET CAP

525.4M

P/E (TTM)

FWD P/E

DAY RANGE

$3 – $3

52W RANGE

$1
$3
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$208.4M$1.5M$392,000$566,000$7.3M
YoY %+1551.6%-99.3%-73.9%+44.4%+1181.3%
P / Sales1.0x90.9x597.8x117.0x16.6x
EV / Sales0.2x76.4x672.2x112.8x17.6x
Gross Profit, Adj.$208.4M$1.5M$392,000$566,000$7.3M
YoY %+1551.6%-99.3%-73.9%+44.4%+1181.3%
Margin %100.0%100.0%100.0%100.0%100.0%
EV / Gross Profit0.2x76.4x672.2x112.8x17.6x
EBITDA, Adj.$124.4M$-54.2M$-58.7M$-61.3M$-42.2M
YoY %+254.2%-143.5%-8.4%-4.4%+31.2%
Margin %59.7%-3604.5%-14977.8%-10825.4%-581.4%
EV / EBITDA0.4x-2.1x-4.5x-1.0x-3.0x
EBIT$124.2M$-55.5M$-59.3M$-61.9M$-42.4M
YoY %+253.3%-144.7%-6.7%-4.4%+31.4%
Margin %59.6%-3696.4%-15122.7%-10933.7%-585.2%
EV / EBIT0.4x-2.1x-4.4x-1.0x-3.0x
Net Income$119.8M$-54.2M$-52.3M$-26.4M$-17.4M
YoY %+247.9%-145.2%+3.4%+49.5%+34.1%
Net Margin57.5%-3604.7%-13351.8%-4670.1%-240.1%
EPS (GAAP)$1.76-$0.77-$0.73-$0.37-$0.23
YoY %+226.6%-143.8%+5.2%+49.3%+37.8%